Zobrazeno 1 - 10
of 13
pro vyhledávání: '"J. G. Ribot"'
Autor:
P. T. R. Rodrigus, Paul Lips, D. A. K. C. J. M. Huijsmans, O. S. Hoekstra, C. Dragoiescu, J. L.P. Kuijpens, M. A. B. D. Plaizier, Jan Willem Coebergh, J. G. Ribot, Gerrit J.J. Teule, D. J. Kuik
Publikováno v:
Clinical Endocrinology. 58:451-455
Summary BACKGROUND Justification for adjuvant radio-iodine (I-131) therapy in differentiated thyroid cancer (DTC) is purely based on retrospective data. This is true for ablative therapy and even more so for high-dosage adjuvant schedules. Randomized
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 24:241-246
A group of 95 patients, treated with irradiation for relapse after radical surgery as only initial treatment modality for a rectal carcinoma was studied. The term locoregional relapse relates to evidence of tumor recurrent in the pelvis or the perine
Autor:
Rene J. E. Grouls, J. G. Ribot, J. L. Slooff, W. F. Boon, F. Bal, M. A. Crommelin, E. W. Ackerman, A. A. J. van Zundert, F. Hoefsloot, Hendrikus H. M. Korsten
Publikováno v:
Anesthesiology. 75:950-960
An aqueous suspension of n-butyl-p-aminobenzoate (BAB), a highly lipid-soluble congener of benzocaine, was applied epidurally in terminally ill cancer patients with intractable pain. The suspension consisted of 10% BAB and 0.025% of the nonionic surf
Autor:
C, Dragoiescu, O S, Hoekstra, D J, Kuik, P, Lips, M A B D, Plaizier, P T R, Rodrigus, D A K C J M, Huijsmans, J G, Ribot, J, Kuijpens, J W W, Coebergh, G J J, Teule
Publikováno v:
Clinical endocrinology. 58(4)
Justification for adjuvant radio-iodine (I-131) therapy in differentiated thyroid cancer (DTC) is purely based on retrospective data. This is true for ablative therapy and even more so for high-dosage adjuvant schedules. Randomized trials on the latt
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 146(10)
To evaluate the treatment of patients with differentiated (papillary or follicular) thyroid cancer in general hospitals in the south-east of the Netherlands during the period 1983-1996, in relation to the 1987 national consensus recommendations.Popul
Autor:
Jan Willem Coebergh, Harm R. Haak, Bettina E. Hansen, J. L.P. Kuijpens, J. G. Ribot, J.F Hamming
Publikováno v:
European Journal of Cancer, 34(8), 1235-1241. Elsevier Ltd.
Thyroid cancer (TC), comprising less than 1% of all cancers in the Netherlands, has a good prognosis in general. Controversy still remains on the extent of surgical treatment and the indication for additional Iodine-131 (131I) therapy in the manageme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30a137aaa4fba2333f9243c9f69c6534
https://pure.eur.nl/en/publications/225702b0-3e50-4e43-937d-38acb34e581c
https://pure.eur.nl/en/publications/225702b0-3e50-4e43-937d-38acb34e581c
Publikováno v:
American journal of clinical oncology. 18(4)
Results are presented of a retrospective study on 178 patients receiving adjuvant postoperative radiotherapy after curative surgery for adenocarcinoma of the rectum and rectosigmoid. Tumorstages according to Gunderson-Sosin were B2: 67, B3: 5, C1: 9,
[Thyroid cancer in Southeastern Netherlands, 1970-1989: trends in incidence, treatment and survival]
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 138(9)
To describe the (changes in) incidence, treatment and prognosis of thyroid cancer (TC) in the period 1970-89 in the South-east of the Netherlands.Eindhoven Cancer Registry, Comprehensive Cancer Centre South (I.K.Z.), Eindhoven.Retrospective.Data were
Publikováno v:
Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique. 81(1)
Between January 1974 and December 1988, 46 patients with cancer of the urinary bladder, stages T1 or T2, and one patient with stage T3, were treated with an interstitial implant at the radiotherapy department of the Catharina Ziekenhuis at Eindhoven,
Autor:
H. Martijn, V. Coen, M.A. Crommelin, Dirk Verellen, W. De Neve, G. Storrne, M.L.M. Lybeert, J. G. Ribot
Publikováno v:
European Journal of Cancer. 29:S174